Transfusion-related acute lung injury (TRALI) - Review;Transfusion-related acute lung injury (TRALI) - Přehledový článek

Ceska Gynekologie

Volumn 78, Issue 2, 2013, Pages 211-215

  Cermakova Z ^a   Simetka O ^b   Koristka M ^a  

^a UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Blood transfusion; Leukocyte antibodies; Mortality; Trali

Indexed keywords

ACUTE LUNG INJURY; ADVERSE EFFECTS; BLOOD TRANSFUSION; HUMAN; IMMUNOLOGY; MORTALITY;

ACUTE LUNG INJURY; BLOOD TRANSFUSION; HUMANS;

EID: 84878458050     PISSN: 12107832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Bernard, GR., Artigas, A., Brigham, KL., et al. Report of the American-European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee. J Crit Care, 1994, 9, p. 72-81.
2. Bux, J. Antibody-mediated (immune) transfusion-related acute lung injury. Vox Sang, 2011, 100, p. 122-128.
3. Bux, J., Sachs, UJH. The pathogenesis of transfusion-related acute lung injury (TRALI). Brit J Hem, 2007, 136, p. 788-799.
4. Čermáková, Z., Kořístka, M., Blahutová, Š., et al. Transfusion-related acute lung injury: Report of two cases. Prag Med Rep, 2012, 113, 4, p. 294-298.
5. Davoren, A., Curtis, BR., Shulman, IA., et al. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) al-loantibodies in donor plasma: a report of 2 fatalities. Transfusion, 2003, 43, p. 641-645.
6. Flesland, O. A comparison of complication rates based on published haemovigilance data. Intensive Care Med, 2007, 33, suppl. 1, p. 17-21.
7. Goldman, M., Webert, KE., Arnold, DM., et al. Proceedings of a consensus conference: toward an understanding of TRALI. Trans Med Rev, 2005, 19, p. 2-31.
8. Chapman, CE., Stainsby, D., Jones, H., et al. Ten years of he-movigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion, 2009, 49, p. 440-452.
9. Keller-Stanislawski, B., Reil, A., Gunay, S., Funk, MB. Frequency and severity of transfusion-related acute lung injury - German haemovigilance data (2006-2007). Vox Sang, 2010, 98, p. 70-77.
10. Khan, SY., Kelher, MR., Heal, JM., et al. Soluble CD40 li-gand accumulates in stored blood components, primes neu-trophils through CD40, and is a potential cofactor in the deve-lopment of transfusion-related acute lung injury. Blood, 2006, 108, p. 2455-2462.
11. Kleinman, S., Caulfield, T., Chan, P., et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion, 2004, 44, p. 1774-1789.
12. Lögdberg, LE., Vikulina, T., Zimring, JC., et al. Animal model of transfusion-related acute lung injury. Transf Med Rev, 2009, 23, p. 13-24.
13. Mair, DC., Eastlund, T. The pathophysiology and prevention of transfusion-related acute lung injury (TRALI): a review. Immunohem, 2010, 26, p. 161-173.
14. Middelburg, RA., van Stein, D., Briet, E., van der Bom, JG. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review. Transfusion, 2008, 48, p. 2167-2176.
15. Moore, SB. Transfusion-related acute lung injury (TRALI): clinical presentation, treatment, and prognosis. Crit Care Med, 2006, 34, Suppl., p. 114-117.
16. Nishimura, M., Hashimoto, S., Takanashi, M., et al. Role of anti-human leucocyte antigen class II alloantibody and monocy-tes in development of transfusion-related acute lung injury. Transf Med, 2007, 17, p. 129-134.
17. Popovsky, MA., Abel, MD., Moore, SB. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis, 1983, 128, p. 185-189.
18. Popovsky, MA., Moore, SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion, 1985, 25, p. 573-577.
19. Reil, A., Keller-Stanislawski, B., Günay, S., Bux, J. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang, 2008, 95, p. 313-317
20. Rizk, A., Gorgon, KC., Kenney, L., Weinstein R. Transfusion-related acute lung injury after the infusion of IVIG. Transfusion, 2001, 41, p. 264-268.
21. Sachs, UJ. Recent insights into mechanism of transfusion-related acute lung injury. Curr Opin Hematol, 2011, 18, p. 436-442.
22. Sachs, UJ., Hattar, K., Weissmann, N., et al. Antibody-induced neutrofil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood, 2006, 107, p. 1217-1219.
23. Sachs, UJ., Wasel, W., Bayat, B., et al. Mechanism of transfusion-related acute lung injury induced by HLA class II antibodies. Blood, 2011, 117, p. 669-677.
24. Seeger, W., Schneider, U., Kreusler, B., et al. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood, 1990, 76, p. 1438-1444.
25. Serious Hazards of Transfusion (SHOT). Annual SHOT Report 2011. Available from http://www.shotuk.org/
26. Shaz, BH., Stowell, SR., Hillyer, CD. Transfusion-related acute lung injury: from bedside to bench and back. Blood, 2011, 117, p. 1463-1471.
27. Silliman, CC., Ambruso, DR., Boshkov, LK. Transfusion-related acute lung injury. Blood, 2005, 105, p. 2266-2273.
28. Silliman, CC., Bjornsen, AJ., Wyman, TH., et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion, 2003, 43, p. 633-640.
29. Silliman, CC., Boshkov, LK., Mehdizadehkashi, Z., et al. Transfusion-related acute lung injury: epidemiology and prospective analysis of etiologic factors. Blood, 2003, 101, p. 454-462.
30. Silliman, CC., Curtis, BR., Kopko, PM., et al. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microva-scular endothelial cells in a two-event in vitro model. Blood, 2007, 109, p. 1752-1755.
31. Silliman, CC., Fung, YL., Ball, JB., Khan, SY. Transfusion-related acute lung injury (TRALI): current concepts and misconceptions. Blood Rev, 2009, 23, p. 245-255.
32. Silliman, CC., Kelher, M. The role of endothelial activation in the pathogenesis of transfusion-related acute lung injury. Transfusion, 2005, 45, Suppl., p. 109-116.
33. Silliman, CC., Voelkel, NF., Allard, JD., et al. Plasma and li-pids from stored red cells cause acute lung injury in an animal model. J Clin Invest, 1998, 101, p. 1458-1467.
34. Sinnott, P., Bodger, S., Gupta, A., Brophy, M. Presence of HLA antibodies in single-donor-derived fresh frozen plasma compared with pooled, solvent detergent-treated plasma (Octaplas). Eur J Immunogenet, 2004, 31, p. 271-274.
35. Toy, P., Popovsky, MA., Abraham, E., et al. Transfusion-related acute lung injury: definition and review. Crit Care Med, 2005, 33, p. 721-726.
36. Triulzi, DJ. Transfusion-related acute lung injury: Current Concepts for Clinician. Anesth and Analg, 2009, 108, p. 770-776.
37. Wallis, JP., Lubenko, A., Wells, AW., Chapman, CE. Single hospital experience of TRALI. Transfusion, 2003, 43, p. 1053-1059.
38. Webert, KE., Blajchman, MA. Transfusion-related acute lung injury. Curr Opin Hematol, 2005, 12, p. 480-487.